Previously Livongo's service was offered only through employers, health providers, and health plans; Livongo Family Care Plan changes that.
The company will use the funds to expand to other chronic conditions, and move to international markets.
Under the deal, the Livongo for Diabetes program will be offered with Voluntis' Insulia, an FDA-cleared medical device and app.
Just like your phone or tablet, Livongo's connected glucose meter will be able to receive software updates and bring along new capabilities.
Livongo combines human support, real-time data, and technology into a diabetes management program that truly engages participants.
In the first phase of the partnership, Humana has made Livongo's diabetes management tools available to a select group of its members.
The company will use the funds to add new clients, accelerate the launch of new products and services, and to expand into new market segments.
Livongo deployment will start with Mount Vernon Mills, a leading textile manufacturer with 15 facilities that employ 2,800 individuals.
The program starts with a smart data analytics platform that captures information from a variety of sources to deliver relevant and timely insights and alerts.
A few investors participated in the round, including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.